Firouz Asgarzadeh, Ph.D.

Firouz Asgarzadeh, Ph.D., is the Founder and President of OSD Pharmaceutical Solutions LLC and a Scientific Advisor at Persist-AI and Procept, bringing over 29 years of global R&D and commercial leadership in formulation development, solubility enhancement, and sustained-release dosage forms. Previously, he held executive and senior scientific roles at BioDuro-Sundia, Evonik, Merck, Catalent, and Alkermes, contributing to numerous marketed products and patented innovations. A recognized Key Opinion Leader, he has chaired and co-chaired industry focus groups on excipients, CRO strategy, and QbD across associations including AAPS, Interphex, and CRBE. Dr. Asgarzadeh holds a Ph.D. in Polymeric Materials and Composites from Université Claude Bernard Lyon 1, an M.S. in Physical Chemistry from Université Louis Pasteur, and an M.S. in Polymer Engineering from Amirkabir University of Technology.